Harvard Bioscience
HBIO
HBIO
81 hedge funds and large institutions have $83.6M invested in Harvard Bioscience in 2013 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 33 increasing their positions, 22 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
72% less call options, than puts
Call options by funds: $128K | Put options by funds: $454K
Holders
81
Holding in Top 10
1
Calls
$128K
Puts
$454K
Top Buyers
| 1 | +$864K | |
| 2 | +$727K | |
| 3 | +$622K | |
| 4 |
BG
BlackRock Group
London,
United Kingdom
|
+$536K |
| 5 |
MOACM
Mutual of America Capital Management
New York
|
+$438K |
Top Sellers
| 1 | -$7.13M | |
| 2 | -$2.46M | |
| 3 | -$601K | |
| 4 |
HMC
Harbert Management Corporation
Birmingham,
Alabama
|
-$563K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$493K |